1 terminated, 1 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 1, Withdrawn 1 |
Follow PRO051: new trials by email Literature Review of PRO051 trials Research Report on PRO051
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol Drisapersen - Muscular Dystrophies | Phase 3 | Withdrawn | GlaxoSmithKline | 2014-01-01 | 2014-03-24 | |
| A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects Drisapersen - Muscular Dystrophies | Phase 3 | Terminated | BioMarin Pharmaceutical | 53 | 2013-05-01 | 2018-06-14 |
Muscular Dystrophies (2) · Muscular Dystrophy, Duchenne (2)
BioMarin Pharmaceutical (1) · GlaxoSmithKline (1)
Canada (1) · United States (1)